Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 4 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2026 Filed Aug 28, 2026 21:01 UTC |
Chappell Amy SuzonDirector
|
PurchaseCommon Stock | 727 | $2.16 | $1,570.32 |
DisclosureSEC source: 0001520138-26-000382 · ownership.xml · nonDerivative · entry 1 Chappell Amy Suzon · CIK 0002090156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 727 F1 · shares: The shares of Common Stock were purchased by the Reporting Person in an open market transaction. Read SEC document |
| August 28, 2026 Filed Aug 28, 2026 21:01 UTC |
Palumbo Joseph MChief Medical Officer
|
PurchaseCommon Stock | 4,843 | $2.16 | $10,460.88 |
DisclosureSEC source: 0001520138-26-000383 · ownership.xml · nonDerivative · entry 1 Palumbo Joseph M · CIK 0001892610 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,036 F1 · price: The shares of Common Stock were purchased in several open market transactions, all at the same price. The reported price does not reflect a weighted average price. Read SEC document |
| August 28, 2026 Filed Aug 28, 2026 20:58 UTC |
KIM JOANNE WENDYChief Financial Officer
|
PurchaseCommon Stock | 2,500 | $2.18 | $5,450.00 |
DisclosureSEC source: 0001520138-26-000379 · ownership.xml · nonDerivative · entry 1 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,441 F1 · shares: The shares of Common Stock were purchased by the Reporting Person in an open market transaction. Read SEC document |
| August 27, 2026 Filed Aug 28, 2026 20:57 UTC |
DO CUONG VDirector · President & CEO
|
PurchaseCommon Stock | 15,210 | $2.08 | $31,636.80 |
DisclosureSEC source: 0001520138-26-000378 · ownership.xml · nonDerivative · entry 1 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,117 F1 · price: The price reported in Column 4 is a weighted average price at which shares were purchased in several open market transactions on August 27, 2026, at prices ranging from $2.05 to $2.10, inclusive. The reporting person undertakes to provide BioVie Inc., any stockholder of BioVie Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 17:02 UTC |
ROGICH SIGMUNDDirector
|
GrantStock Option (right to buy) · Derivative | 141,100 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000022 · ownership.xml · derivative · entry 2 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,100 Underlying: Common Stock · 141,100 shares Expires 2031-01-05 F2 · derivative.exercise_date: 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 17:02 UTC |
ROGICH SIGMUNDDirector
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000022 · ownership.xml · derivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-01-05 F1 · derivative.exercise_date: The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 22:01 UTC |
Farag Kameel D.Director
|
GrantStock Option (right to buy) · Derivative | 57,500 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000019 · ownership.xml · derivative · entry 1 Farag Kameel D. · CIK 0002093620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 Underlying: COMMON STOCK · 57,500 shares Expires 2031-01-05 F1 · derivative.exercise_date: 7,500 shares of the underlying options vest s on grant date and the remaining balance in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 17:00 UTC |
Chappell Amy SuzonDirector
|
GrantStock Option (right to buy) · Derivative | 57,500 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000018 · ownership.xml · derivative · entry 1 Chappell Amy Suzon · CIK 0002090156 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 Underlying: Common Stock · 57,500 shares Expires 2031-01-05 F1 · derivative.exercise_date: 7,500 shares underlying the options vest on grant date and the remaining balance will vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 17:01 UTC |
Sherman Michael EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 341,100 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000020 · ownership.xml · derivative · entry 2 Sherman Michael Edward · CIK 0001730468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,100 Underlying: Common Stock · 341,100 shares Expires 2031-01-05 F2 · derivative.exercise_date: 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 17:01 UTC |
Sherman Michael EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000020 · ownership.xml · derivative · entry 1 Sherman Michael Edward · CIK 0001730468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2031-01-05 F1 · derivative.exercise_date: The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 22:02 UTC |
DO CUONG VDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 665,300 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000021 · ownership.xml · derivative · entry 1 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 665,300 Underlying: Common Stock · 665,300 shares Expires 2036-01-05 F1 · derivative.exercise_date: 55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029. F2 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 22:03 UTC |
Palumbo Joseph MChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 132,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000024 · ownership.xml · derivative · entry 1 Palumbo Joseph M · CIK 0001892610 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,000 Underlying: Common Stock · 132,000 shares Expires 2036-01-05 F1 · derivative.exercise_date: 55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029 Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 22:03 UTC |
KIM JOANNE WENDYChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 110,100 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000023 · ownership.xml · derivative · entry 1 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,100 Underlying: Common Stock · 110,100 shares Expires 2036-01-05 F1 · derivative.exercise_date: 55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 22:00 UTC |
Lang James PaulDirector
|
GrantStock Option (right to buy) · Derivative | 330,500 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000017 · ownership.xml · derivative · entry 2 Lang James Paul · CIK 0001703090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,500 Underlying: Common Stock · 330,500 shares Expires 2031-01-05 F2 · derivative.exercise_date: 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 22:00 UTC |
Lang James PaulDirector
|
GrantStock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000017 · ownership.xml · derivative · entry 1 Lang James Paul · CIK 0001703090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2031-01-05 F1 · derivative.exercise_date: The options vest in four equal installments on February 10, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. Read SEC document |
| August 07, 2025 Filed Aug 13, 2025 20:05 UTC |
DO CUONG VDirector · President & CEO
|
PurchaseWarrants (right to buy) · Derivative | 5,000 | Not disclosed Strike: $2.50 | Not disclosed |
DisclosureSEC source: 0001520138-25-000251 · ownership.xml · derivative · entry 2 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,050 Underlying: Common Stock · 5,000 shares Expires 2030-08-11 F1 · price: The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $2.00 in connection with the issuer's public offering that closed on August 11, 2025. F2 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| August 07, 2025 Filed Aug 13, 2025 20:05 UTC |
DO CUONG VDirector · President & CEO
|
PurchaseCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520138-25-000251 · ownership.xml · nonDerivative · entry 1 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 9,992 F1 · price: The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $2.00 in connection with the issuer's public offering that closed on August 11, 2025. F2 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 17:24 UTC |
BERMAN RICHARD JDirector
|
GrantStock Option (right to buy) · Derivative | 23,155 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000024 · ownership.xml · derivative · entry 2 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,155 Underlying: Common Stock · 23,155 shares Expires 2029-12-20 F2 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 17:26 UTC |
ROGICH SIGMUNDDirector
|
GrantStock Option (right to buy) · Derivative | 22,070 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000026 · ownership.xml · derivative · entry 2 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,070 Underlying: Common Stock · 22,070 shares Expires 2029-12-20 F2 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 17:21 UTC |
Sherman Michael EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 23,325 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000022 · ownership.xml · derivative · entry 2 Sherman Michael Edward · CIK 0001730468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,325 Underlying: Common Stock · 23,325 shares Expires 2029-12-20 F2 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. F2 · balance_after: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 22:01 UTC |
DO CUONG VDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 104,502 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000010 · ownership.xml · derivative · entry 1 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 104,502 Underlying: Common Stock · 104,502 shares Expires 2034-12-20 F1 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. F2 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 22:06 UTC |
Hariri Robert JDirector
|
GrantStock Option (right to buy) · Derivative | 21,815 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000016 · ownership.xml · derivative · entry 2 Hariri Robert J · CIK 0001398815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,815 Underlying: Common Stock · 21,815 shares Expires 2029-12-20 F2 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 22:19 UTC |
Lang James PaulDirector
|
GrantStock Option (right to buy) · Derivative | 22,690 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000020 · ownership.xml · derivative · entry 2 Lang James Paul · CIK 0001703090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,690 Underlying: Common Stock · 22,690 shares Expires 2029-12-20 F2 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 22:05 UTC |
Palumbo Joseph MChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 15,417 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000014 · ownership.xml · derivative · entry 1 Palumbo Joseph M · CIK 0001892610 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,417 Underlying: Common Stock · 15,417 shares Expires 2034-12-20 F1 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 22:03 UTC |
KIM JOANNE WENDYChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 14,417 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000012 · ownership.xml · derivative · entry 1 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,417 Underlying: Common Stock · 14,417 shares Expires 2034-12-20 F1 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| November 20, 2024 Filed Jan 7, 2025 17:24 UTC |
BERMAN RICHARD JDirector
|
GrantCommon Stock | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-25-000024 · ownership.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,643 F1 · shares: Represents a restricted stock unit ("RSU") grant, which was approved by the compensation committee of the issuer's board of directors, subject to board approval, which was obtained on November 20, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting. Read SEC document |
| November 20, 2024 Filed Jan 7, 2025 17:26 UTC |
ROGICH SIGMUNDDirector
|
GrantCommon Stock | 32,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-25-000026 · ownership.xml · nonDerivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,926 F1 · shares: Represents a restricted stock unit ("RSU") grant, which was approved by the compensation committee of the issuer's board of directors, subject to board approval, which was obtained on November 20, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting. Read SEC document |
| November 20, 2024 Filed Jan 7, 2025 17:21 UTC |
Sherman Michael EdwardDirector
|
GrantStock Option (right to buy) · Derivative | 56,900 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001520138-25-000022 · ownership.xml · derivative · entry 1 Sherman Michael Edward · CIK 0001730468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,900 Underlying: Common Stock · 56,900 shares Expires 2029-11-20 F1 · derivative.exercise_date: The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting. Read SEC document |
| November 20, 2024 Filed Jan 7, 2025 22:06 UTC |
Hariri Robert JDirector
|
GrantStock Option (right to buy) · Derivative | 49,800 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001520138-25-000016 · ownership.xml · derivative · entry 1 Hariri Robert J · CIK 0001398815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,800 Underlying: Common Stock · 49,800 shares Expires 2029-11-20 F1 · derivative.exercise_date: The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting. Read SEC document |
| November 20, 2024 Filed Jan 7, 2025 22:19 UTC |
Lang James PaulDirector
|
GrantStock Option (right to buy) · Derivative | 61,600 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001520138-25-000020 · ownership.xml · derivative · entry 1 Lang James Paul · CIK 0001703090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,600 Underlying: Common Stock · 61,600 shares Expires 2029-11-20 F1 · derivative.exercise_date: The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:01 UTC |
DO CUONG VDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 227,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001520138-24-000239 · ownership.xml · derivative · entry 6 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 227,000 Underlying: Common Stock · 227,000 shares Expires 2034-06-24 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on June 24, 2024. F3 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:01 UTC |
DO CUONG VDirector · President & CEO
|
Tax withholdingCommon Stock | 42,000 | $0.47 | $19,908.00 |
DisclosureSEC source: 0001520138-24-000239 · ownership.xml · nonDerivative · entry 4 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 551,948 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024. F3 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:01 UTC |
DO CUONG VDirector · President & CEO
|
GrantCommon Stock | 168,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-24-000239 · ownership.xml · nonDerivative · entry 3 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 593,948 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024. F3 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:01 UTC |
KIM JOANNE WENDYChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 99,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001520138-24-000240 · ownership.xml · derivative · entry 5 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 99,000 shares Expires 2034-06-24 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on June 24, 2024. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:01 UTC |
KIM JOANNE WENDYChief Financial Officer
|
Tax withholdingCommon Stock | 18,250 | $0.47 | $8,650.50 |
DisclosureSEC source: 0001520138-24-000240 · ownership.xml · nonDerivative · entry 4 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,940 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:01 UTC |
KIM JOANNE WENDYChief Financial Officer
|
GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-24-000240 · ownership.xml · nonDerivative · entry 3 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,196 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:02 UTC |
Palumbo Joseph MChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 156,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001520138-24-000241 · ownership.xml · derivative · entry 5 Palumbo Joseph M · CIK 0001892610 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,000 Underlying: Common Stock · 156,000 shares Expires 2034-06-24 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on June 24, 2024. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:02 UTC |
Palumbo Joseph MChief Medical Officer
|
Tax withholdingCommon Stock | 29,000 | $0.47 | $13,746.00 |
DisclosureSEC source: 0001520138-24-000241 · ownership.xml · nonDerivative · entry 4 Palumbo Joseph M · CIK 0001892610 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,196 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024. Read SEC document |
| June 24, 2024 Filed Jul 12, 2024 22:02 UTC |
Palumbo Joseph MChief Medical Officer
|
GrantCommon Stock | 116,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-24-000241 · ownership.xml · nonDerivative · entry 3 Palumbo Joseph M · CIK 0001892610 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,196 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:12 UTC |
DO CUONG VDirector · President & CEO
|
PurchaseWarrants (right to buy) · Derivative | 5,000 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001520138-24-000099 · ownership.xml · derivative · entry 2 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-03-04 F1 · price: The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $1.00 in connection with the issuer's public offering that closed on March 6, 2024. F2 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:12 UTC |
DO CUONG VDirector · President & CEO
|
PurchaseCommon stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520138-24-000099 · ownership.xml · nonDerivative · entry 1 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 435,854 F1 · price: The reported securities were purchased by the reporting person at a combined purchase price for a share of common stock and accompanying warrant equal to $1.00 in connection with the issuer's public offering that closed on March 6, 2024. F2 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| February 15, 2024 Filed Jul 12, 2024 22:01 UTC |
DO CUONG VDirector · President & CEO
|
Tax withholdingCommon Stock | 4,953 | $1.18 | $5,844.54 |
DisclosureSEC source: 0001520138-24-000239 · ownership.xml · nonDerivative · entry 2 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 425,948 F3 · ownership.nature: Securities are held in the name of Do & Rickles Investments LLC. Read SEC document |
| February 15, 2024 Filed Jul 12, 2024 22:01 UTC |
KIM JOANNE WENDYChief Financial Officer
|
Tax withholdingCommon Stock | 2,476 | $1.18 | $2,921.68 |
DisclosureSEC source: 0001520138-24-000240 · ownership.xml · nonDerivative · entry 2 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,196 Read SEC document |
| February 15, 2024 Filed Jul 12, 2024 22:02 UTC |
Palumbo Joseph MChief Medical Officer
|
Tax withholdingCommon Stock | 2,476 | $1.18 | $2,921.68 |
DisclosureSEC source: 0001520138-24-000241 · ownership.xml · nonDerivative · entry 2 Palumbo Joseph M · CIK 0001892610 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,196 Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:15 UTC |
KIM JOANNE WENDYChief Financial Officer
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-23-000547 · ownership.xml · nonDerivative · entry 1 KIM JOANNE WENDY · CIK 0001771317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,148 Read SEC document |
| December 01, 2023 Filed Dec 6, 2023 16:16 UTC |
GORLIN STEVEDirector
|
SaleCommon Stock | 75,680 | $1.69 | $127,899.20 |
DisclosureSEC source: 0001520138-23-000534 · ownership.xml · nonDerivative · entry 2 GORLIN STEVE · CIK 0001033742 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,358 Read SEC document |
| November 30, 2023 Filed Dec 1, 2023 23:26 UTC |
DO CUONG VDirector · President & CEO
|
PurchaseCommon stock | 10,000 | $1.78 | $17,800.00 |
DisclosureSEC source: 0001520138-23-000522 · ownership.xml · nonDerivative · entry 1 DO CUONG V · CIK 0001477037 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,759 Read SEC document |
| November 09, 2023 Filed Dec 6, 2023 16:16 UTC |
GORLIN STEVEDirector
|
GrantCommon Stock | 46,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-23-000534 · ownership.xml · nonDerivative · entry 1 GORLIN STEVE · CIK 0001033742 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,038 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting. Read SEC document |
| November 09, 2023 Filed Dec 6, 2023 16:15 UTC |
BERMAN RICHARD JDirector
|
GrantCommon Stock | 51,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-23-000530 · ownership.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,235 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting. F2 · balance_after: On August 22, 2023, the reporting person filed a Form 4 which inadvertently reported that, following his exercise of an option and sale of the underlying stock, he directly owned 16,789 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 17,405 shares of common stock. Read SEC document |
| November 09, 2023 Filed Dec 6, 2023 16:16 UTC |
ROGICH SIGMUNDDirector
|
GrantCommon Stock | 42,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-23-000533 · ownership.xml · nonDerivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,254 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.